CMDB program and Cunningham lab alumnus, Myriam Heiman, among one of the recipients of the 2021 NIH Director’s Transformative Research Award for her project titled, “Identification of TDP-43 Modifiers Through Single-Cell Transcriptional and Epigenomic Dissection of ALS and FTLD-MND”. This prestigious award supports exceptionally innovative or unconventional research projects with the potential to create new scientific paradigms.
Congratulations to Dr. Heiman!
Read more about the 2021 TRA Recipients: https://commonfund.nih.gov/tra/recipients
Read more about Dr. Heiman’s research: https://heiman.mit.edu/myriam-heiman/